Allspring Global Investments
EBS icon

Allspring Global Investments’s Emergent Biosolutions EBS Stock Holding History

Allspring Global Investments’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-191,577
Closed -$1.83M – 1754
2024
Q4 		$1.83M Buy
+191,577
New +$1.76M ﹤0.01% 1159
2024
Q3 		– Sell
-1,121
Closed -$7.64K – 2497
2024
Q2 		$7.64K Buy
+1,121
New +$4.82K ﹤0.01% 2206
2024
Q1 		– Sell
-460,289
Closed -$1.1M – 2326
2023
Q4 		$1.1M Buy
460,289
+6,724
+1% +$15.8K ﹤0.01% 1318
2023
Q3 		$1.54M Buy
453,565
+153,850
+51% +$853K ﹤0.01% 1258
2023
Q2 		$2.2M Buy
299,715
+287,467
+2,347% +$2.67M ﹤0.01% 1202
2023
Q1 		$127K Buy
12,248
+6,660
+119% +$80.5K ﹤0.01% 1957
2022
Q4 		$66K Buy
5,588
+187
+3% +$2.89K ﹤0.01% 2231
2022
Q3 		$113K Buy
5,401
+2,863
+113% +$79.7K ﹤0.01% 2033
2022
Q2 		$78K Sell
2,538
-54,564
-96% -$1.86M ﹤0.01% 2130
2022
Q1 		$2.34M Buy
57,102
+1,722
+3% +$76K ﹤0.01% 1418
2021
Q4 		$2.41M Buy
+55,380
New +$2.51M ﹤0.01% 1448

Other funds holding EBS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
OHA
Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Allspring Global Investments's EBS Position: Q1 2025 in Review

Allspring Global Investments sold out of Emergent Biosolutions (EBS) in Q1 2025, closing a stake of 191,577 shares — an estimated $1.83M sold.

Allspring Global Investments first reported a position in EBS in Q4 2021 and held it in 11 quarters. The position peaked at $2.41M in Q4 2021. 160 funds tracked by Wall St. Rank hold EBS as of Q1 2025.

  • Allspring Global Investments reported no remaining Emergent Biosolutions position as of Q1 2025 after selling out during the quarter.
  • Allspring Global Investments sold 191,577 Emergent Biosolutions shares in Q1 2025, an estimated $1.83M.
  • Allspring Global Investments first reported a position in Emergent Biosolutions in Q4 2021 and held it in 11 quarters.
  • Allspring Global Investments's Emergent Biosolutions position peaked at $2.41M in Q4 2021.
  • 160 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2025.

Based on Allspring Global Investments's 13F filing for Q1 2025, filed 24 Apr 2025.